In our experiment, EGFR-TKIs inhibited CCR7 protein levels, in addition to reducing VEGFC expression, and these results indicate the strong anti-lymphangiogenesis activity of EGFR-TKIs in NSCLC. The gene discussed is CCR7; the disease is non-small cell lung carcinoma.